Benefits of Herbal Medicine on Bone Mineral Density in Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.

Published on Dec 10, 2020in The American Journal of Chinese Medicine3.682
· DOI :10.1142/S0192415X20500871
Wan-Ling Lin , Pao-Yen Lin26
Estimated H-index: 26
(CGU: Chang Gung University)
+ 1 AuthorsTun-Pin Hsueh (NYMU: National Yang-Ming University)
Sources
Abstract
Bone mineral density (BMD) has been validated not only for the diagnosis of osteoporosis but also for prediction of the risk of osteoporosis-related fractures. The purpose of this paper was to investigate the overall benefits of herbal medicines on BMD using a meta-analytic method. Systematic searches in PubMed, Medline, Cochrane Central, and China National Knowledge Infrastructure were performed for eligible studies. A meta-analysis was conducted to evaluate the benefits of herbal medicine treatment and conventional treatment for BMD. Herbal medicines frequently used for interventions were pooled in the analysis and further investigated. Seventeen studies were pooled in the meta-analysis and showed that BMD was higher in the herbal medicine group than in the control group (standardized mean difference [SMD]: 0.857; 95% confidence interval [CI]: 0.412 to 1.301). Significant benefits of herbal medicine for BMD were found in the lumbar spine, femoral neck, and femoral trochanter and in postmenopausal women (SMD: 0.600, 95% CI: 0.068 to 1.131) by subgroup analysis. Moreover, through the meta-regression analysis, the age at menopause and the menopause duration were found to influence the herbal intervention effects on BMD. In addition, the most prescribed medicine among the effective herbs in the pooled studies was found to be Epimedium brevicornum Maxim. This paper provides evidence that herbal medicine interventions increase BMD more than conventional treatments in individuals with osteoporosis, especially postmenopausal women. The results of this study suggest that herbal medicines are effective for increasing BMD in individuals with osteoporosis.
📖 Papers frequently viewed together
20161.55Medicine
7 Authors (Shenghan Lou, ..., Peifu Tang)
9 Citations
45 Citations
2 Citations
References39
Newest
#1Jiahong Meng (ZJU: Zhejiang University)H-Index: 7
#2Wenkan Zhang (ZJU: Zhejiang University)H-Index: 3
Last. Weiqi Yan (ZJU: Zhejiang University)H-Index: 19
view all 9 authors...
Abstract Excessive activation of osteoclast activity is responsible for many bone diseases, such as osteoporosis, rheumatoid arthritis, periprosthetic osteolysis, and periodontitis. Natural compounds that inhibit osteoclast formation and/or function have therapeutic potential for treating these diseases. Catalpol, a bioactive iridoid extracted from a traditional herbal medicine Rehmannia glutinosa, exhibits various pharmacological properties, including anti-inflammatory, antioxidant, antidiabeti...
4 CitationsSource
#1Wan Gong (ZJNU: Zhejiang Chinese Medical University)H-Index: 1
#2Naidan Zhang ('SMMU': Second Military Medical University)H-Index: 7
Last. Lu-Ping Qin (ZJNU: Zhejiang Chinese Medical University)H-Index: 39
view all 10 authors...
Rehmanniae Radix Praeparata (RR, named as Shudihuang in traditional Chinese medicine), the steamed roots of Rehmannia glutinosa Libosch (Scrophulariaceae), has been demonstrated to have anti-diabetic and anti-osteoporotic activities. This study aimed to explore the protective effect and underlying mechanism of RR on diabetes-induced bone loss. It was found that RR regulated the alkaline phosphatase activity and osteocalcin level, enhanced bone mineral density, and improved the bone microarchitec...
12 CitationsSource
#1Chenyue Liu (Beijing University of Chinese Medicine)H-Index: 10
#2Lili Wang (Beijing University of Chinese Medicine)H-Index: 12
Last. Dongwei Zhang (Beijing University of Chinese Medicine)H-Index: 20
view all 19 authors...
Summary Rehmanniae Radix Preparata (RRP) improves bone quality in OVX rats through the regulation of bone homeostasis via increasing osteoblastogenesis and decreasing osteoclastogenesis, suggesting it has a potential for the development of new anti-osteoporotic drugs.
8 CitationsSource
#1Tianshuang Xia ('SMMU': Second Military Medical University)H-Index: 3
#2Xin Dong ('SMMU': Second Military Medical University)H-Index: 15
Last. Lu-Ping Qin ('SMMU': Second Military Medical University)H-Index: 39
view all 9 authors...
Rehmanniae Radix Preparata (RR), the dry rhizome of Rehmannia glutinosa Libosch., is a traditional herbal medicine for improving the liver and kidney function. Ample clinical and pharmacological experiments show that RR can prevent post-menopausal osteoporosis and senile osteoporosis. In the present study, in vivo and in vitro experiments, as well as a UHPLC-Q/TOF-MS-based metabolomics study, were used to explore the preventing effect of RR on glucocorticoid-induced osteoporosis (GIOP) and its u...
9 CitationsSource
#1Ching-Lung Cheung (HKU: University of Hong Kong)H-Index: 26
#2Seng Bin Ang (Boston Children's Hospital)H-Index: 7
Last. Saeko FujiwaraH-Index: 5
view all 13 authors...
Abstract Objectives Hip fracture is a major public health problem. Earlier studies projected that the total number of hip fracture will increase dramatically by 2050, and most of the hip fracture will occur in Asia. To date, only a few studies provided the updated projection, and none of them focused on the hip fracture projection in Asia. Thus, it is essential to provide the most up to date prediction of hip fracture in Asia, and to evaluate the total direct medical cost of hip fracture in Asia...
70 CitationsSource
#1Micol S. Rothman (University of Colorado Denver)H-Index: 11
#2E. Michael LewieckiH-Index: 48
Last. Paul D. MillerH-Index: 63
view all 3 authors...
1 CitationsSource
#1Shannon D. Sullivan (FDA: Food and Drug Administration)H-Index: 3
#2Amy Lehman (OSU: Ohio State University)H-Index: 41
Last. Barbara V. Howard (Memorial Hospital of South Bend)H-Index: 105
view all 5 authors...
We previously reported that in the absence of hormone therapy (HT) or calcium/vitamin D (Ca/D) supplementation, earlier menopause age was associated with decreased bone mineral density and increased fracture risk in healthy postmenopausal women. Treatment with HT and Ca/D is protective against fractures after menopause. In this analysis, we asked if the age of menopause onset alters fracture risk in healthy postmenopausal women receiving HT, Ca/D, or a combination. Hazard ratios (HRs) for any fr...
20 CitationsSource
#1Chenyue Liu (Beijing University of Chinese Medicine)H-Index: 10
#2Rufeng Ma (Beijing University of Chinese Medicine)H-Index: 12
Last. Sihua Gao (Beijing University of Chinese Medicine)H-Index: 17
view all 14 authors...
Abstract Ethnopharmacological relevance Emerging clinical usage and pharmacological effects have been achieved in using Rehmanniae Radix either singly or in combination with other herbs to treat skeletal diseases in traditional Chinese medicine (TCM) in the recent years. This study is aimed to provide a comprehensive review about the historical TCM interpretation of the action of Rehmanniae Radix in osteoporosis, its usage in clinical trials and osteoporotic models, its main phytochemical consti...
43 CitationsSource
#1Naidan Zhang ('SMMU': Second Military Medical University)H-Index: 7
#2Ting Han ('SMMU': Second Military Medical University)H-Index: 34
Last. Yi-min Li ('SMMU': Second Military Medical University)H-Index: 2
view all 10 authors...
Abstract Ethnopharmacological relevance Osteoporosis is a chronic epidemic which can leads to enhanced bone fragility and consequent an increase in fracture risk. Traditional Chinese medicine (TCM) formulas have a long history of use in the prevention and treatment of osteoporosis. Antiosteoporotic TCM formulas have conspicuous advantage over single drugs. Systematic data mining of the existing antiosteoporotic TCM formulas database can certainly help the drug discovery processes and help the id...
61 CitationsSource
#1Jen-Chun Wang (NDMC: National Defense Medical Center)H-Index: 5
#2Wu-Chien Chien (NDMC: National Defense Medical Center)H-Index: 14
Last. Shih-Hung Tsai (NDMC: National Defense Medical Center)H-Index: 16
view all 5 authors...
Abstract Background Bisphosphonates (BPs) are a class of medications used for the treatment of osteoporosis. Nitrogen-containing BPs (N-BPs) are more potent than non-nitrogenous BPs in terms of their effects on osteoporosis. We examined the effects of N-BPs on osteoporosis in patients included in a large population-based cohort study. Methods Based on the National Health Insurance Research Database of Taiwan, we identified 1258 patients with osteoporosis who had received N-BP treatment from 2005...
13 CitationsSource
Cited By0
Newest